Specify a stock or a cryptocurrency in the search bar to get a summary
Icecure Medical
ICCMIceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel. Address: 7 Ha?Eshel Street, Caesarea, Israel, 3079504
Analytics
WallStreet Target Price
3.2 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures ICCM
Dividend Analytics ICCM
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ICCM
Stock Valuation ICCM
Financials ICCM
Results | 2019 | Dynamics |